Table 1.
Demographic and clinical characteristics of the patient cohorts.
| Characteristics | ICUCovid | NeuroCovid | ALS | Healthy |
|---|---|---|---|---|
| N | 79 | 78 | 51 | 20 |
| Age at sampling, years, median (IQR) |
65 (58–70) |
61 (53-71) |
67 (62-71) |
61 (58-63) |
| Sex (% males) | 77% | 73% | 51% | 35% |
| Hospitalization, days, median (IQR) | 17 (10-28) |
29 (10-51) |
– | – |
| Mortality (% deceased) |
34% | 16% | – | – |
| PaO2/FIO2 ratio, median (IQR) | 131 (93-180) |
– | – | – |
| ALSFRS-R1 at sampling, median (IQR) | – | – | 33 (22-38) |
– |
1ALSFRS-R: Revised Amyotrophic Lateral Sclerosis Functional Rating Scale.